Barinthus Biotherapeutics plc. (BRNS) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $70.46M | -36.3% |
| 2024 | $110.66M | -22.1% |
| 2023 | $142.09M | -26.9% |
| 2022 | $194.38M | -9.2% |
| 2021 | $214.05M | +394.7% |
| 2020 | $43.27M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $70.46M | -36.3% |
| 2024 | $110.66M | -22.1% |
| 2023 | $142.09M | -26.9% |
| 2022 | $194.38M | -9.2% |
| 2021 | $214.05M | +394.7% |
| 2020 | $43.27M | — |